Dexamethasone錠劑為具有抗炎，抗過敏及抗僂麻質斯等作用之合成皮質類固醇 製劑，因其劑量甚低，品質控制不易，為暸解現階段市售Dexamethasone錠劑之品 質狀況，函請臺北市政府衛生局、高雄市政府衛生局及部分縣市衛生局於民國八十 八年七月至八十八年十二月間，就轄區内醫院、藥局、藥廠及輸入代理商予以抽 樣，計抽驗36件檢體，依據美國藥典所載方法進行檢驗，結果含量測定不符合規定 者1件，不合格率為2.8%。本調查係本局之比較檢驗，曾於八十九年五月，三十曰發 布新聞在案。

Thirty-six samples of dexamethasone tablets, imported or manufactured by local pharmaceutical factories in Taiwan, were collected randomly via local health authorities. These samples were analyzed to evaluate the quality . The analysis included four tests according to the methods of the United States Pharmacopoeia XX and the United States Pharmacopoeia 24. The results showed that 1 sample (2.8%) failed to meet the assay requirement of the government regulation. In conclusion , it is recommended that the manufacturers should emphasize on their manufacturing techniques , quality control systems and composition of pharmaceuticals to comply with government regulations.